$4.4m R&D Tax Incentive Received
Filed with ASX · · 1 page · English
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallGenetic Signatures Limited [ASX:GSS] (“GSS” or the “Company”), a global molecular diagnostics company, is pleased to announce that it has received a refund from the Australian Taxation Office under its Research and Development (“R&D”) tax incentive program in the amount of $4,382,365. The R&D tax incentive is an Australian Government program under which companies receive cash refunds for eligible
Genetic Signatures Ltd. on 6ix
In the deck
Story so far
Earlier from Genetic Signatures
- FY25 Market Update
- FY25 Results Release
- FY25 Appendix 4E and Annual Report
- Strategic Partnership with Tecan and Repado
- 1H FY25 Market Update
Later from Genetic Signatures
- Leadership Change at Genetic Signatures Limited
- Quarterly Activities/Appendix 4C Cash Flow Report
- Genetic Signatures Appoints Maria Halasz as CEO
- GSS Appoints Anne Lockwood as Interim Managing Director
- 1H FY26 Appendix 4D and Half Year Report
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures